PulseAugur
EN
LIVE 12:54:31

Reed Jobs's Yosemite raises $350M for non-lethal cancer initiatives

By PulseAugur Editorial · [1 sources] ·

Reed Jobs's venture firm Yosemite has successfully raised $350 million for its second fund, significantly increasing its capital from the initial close of $200 million. The firm's mission is to invest in technologies and research aimed at making cancer a non-lethal disease, rather than seeking a complete cure. Yosemite employs a unique model that combines traditional venture investing in startups with philanthropic grants to scientists for early-stage idea testing. AI

IMPACT This funding could accelerate AI-driven drug discovery and research aimed at making cancer a manageable, non-lethal condition.

RANK_REASON Significant funding round for a venture firm focused on a major health initiative. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on Fortune →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Reed Jobs's Yosemite raises $350M for non-lethal cancer initiatives

How we ranked this

Signal score
35 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
Significant funding round for a venture firm focused on a major health initiative. [lever_c_demoted from significant: ic=1 ai=0.7]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
funding, product
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
Breaking (< 6h)
Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Fortune TIER_1 English(EN) · Allie Garfinkle ·

    Reed Jobs’s Yosemite raises $350 million second fund to make cancer non-lethal

    Yosemite has closed its cancer-focused second fund at $350 million, a serious jump from January’s first close at $200 million, investor Reed Jobs exclusively told Fortune.

RELATED ENTITIES

RELATED TOPICS